19-38502907-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_000540.3(RYR1):​c.7863C>T​(p.His2621=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.154 in 1,610,390 control chromosomes in the GnomAD database, including 21,001 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. HL2621HL) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.17 ( 2367 hom., cov: 30)
Exomes 𝑓: 0.15 ( 18634 hom. )

Consequence

RYR1
NM_000540.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:17O:1

Conservation

PhyloP100: -0.284
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 19-38502907-C-T is Benign according to our data. Variant chr19-38502907-C-T is described in ClinVar as [Benign]. Clinvar id is 93294.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-38502907-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.284 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.29 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RYR1NM_000540.3 linkuse as main transcriptc.7863C>T p.His2621= synonymous_variant 49/106 ENST00000359596.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RYR1ENST00000359596.8 linkuse as main transcriptc.7863C>T p.His2621= synonymous_variant 49/1065 NM_000540.3 A2P21817-1
RYR1ENST00000355481.8 linkuse as main transcriptc.7863C>T p.His2621= synonymous_variant 49/1051 P4P21817-2
RYR1ENST00000594335.5 linkuse as main transcriptc.1317C>T p.His439= synonymous_variant, NMD_transcript_variant 10/491
RYR1ENST00000599547.6 linkuse as main transcriptc.7863C>T p.His2621= synonymous_variant, NMD_transcript_variant 49/802

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
25762
AN:
151396
Hom.:
2356
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.183
Gnomad AMI
AF:
0.252
Gnomad AMR
AF:
0.174
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.303
Gnomad SAS
AF:
0.284
Gnomad FIN
AF:
0.152
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.145
Gnomad OTH
AF:
0.176
GnomAD3 exomes
AF:
0.178
AC:
44347
AN:
249480
Hom.:
4516
AF XY:
0.181
AC XY:
24493
AN XY:
135000
show subpopulations
Gnomad AFR exome
AF:
0.189
Gnomad AMR exome
AF:
0.137
Gnomad ASJ exome
AF:
0.165
Gnomad EAS exome
AF:
0.295
Gnomad SAS exome
AF:
0.285
Gnomad FIN exome
AF:
0.156
Gnomad NFE exome
AF:
0.146
Gnomad OTH exome
AF:
0.178
GnomAD4 exome
AF:
0.153
AC:
222891
AN:
1458878
Hom.:
18634
Cov.:
37
AF XY:
0.157
AC XY:
113791
AN XY:
725842
show subpopulations
Gnomad4 AFR exome
AF:
0.188
Gnomad4 AMR exome
AF:
0.141
Gnomad4 ASJ exome
AF:
0.171
Gnomad4 EAS exome
AF:
0.275
Gnomad4 SAS exome
AF:
0.278
Gnomad4 FIN exome
AF:
0.154
Gnomad4 NFE exome
AF:
0.136
Gnomad4 OTH exome
AF:
0.166
GnomAD4 genome
AF:
0.170
AC:
25809
AN:
151512
Hom.:
2367
Cov.:
30
AF XY:
0.175
AC XY:
12985
AN XY:
74034
show subpopulations
Gnomad4 AFR
AF:
0.184
Gnomad4 AMR
AF:
0.173
Gnomad4 ASJ
AF:
0.170
Gnomad4 EAS
AF:
0.303
Gnomad4 SAS
AF:
0.285
Gnomad4 FIN
AF:
0.152
Gnomad4 NFE
AF:
0.145
Gnomad4 OTH
AF:
0.182
Alfa
AF:
0.108
Hom.:
257
Bravo
AF:
0.171
Asia WGS
AF:
0.337
AC:
1167
AN:
3472
EpiCase
AF:
0.156
EpiControl
AF:
0.152

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:17Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 09, 2013- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 15, 2013- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 28, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesApr 02, 2018- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 13, 2015p.His2621His in exon 49 of RYR1: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 18.9% (834/4406) of African American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2229142). -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
not provided Uncertain:1Benign:1Other:1
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-Allele frequency is common in at least one population database (frequency: 29.482% in gnomAD_Exomes) based on the frequency threshold of 2.223% for this gene. Variant was observed in a homozygous state in population databases more than expected for disease. 9 reputable source/s reports the variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation. A synonymous variant not located in a splice region. -
not provided, no classification providedliterature onlyLeiden Muscular Dystrophy (RYR1)-- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Congenital multicore myopathy with external ophthalmoplegia Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Central core myopathy Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Malignant hyperthermia, susceptibility to, 1 Benign:2
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 29, 2019- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
RYR1-related disorder Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Neuromuscular disease, congenital, with uniform type 1 fiber Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
King Denborough syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabNov 07, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
7.3
DANN
Benign
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2229142; hg19: chr19-38993547; COSMIC: COSV62092485; API